The “2023 Ophthalmic Laser Market Report” provides new insights into total global laser treatments—including treatments for glaucoma (SLT, iridotomy, ECP), retinal disease (medical and surgical treatments), and secondary cataract. The report includes sections that examine country-level procedure estimates and the top markets for replacement sales versus new installs. It also has refreshed surgeon poll data on adoption plans for retinal rejuvenation therapy, trends in floater treatment, and opinions on emerging glaucoma laser technologies.
A corporate account gives you access to licensed reports and subscriptions, the latest news, a personalized dashboard, and weekly emails with news and data.